Page 172 - FINAL PROGRAM

P-562 Am I ready for ICSI? Individualized training for laboratory technicians and assessment of learning curves
M. Durban Llenas (Spain)
P-563 Separated double embryo transfer represents a novel method in assisted reproductive technology treatment to prevent multiple pregnancies
T. Hasegawa (Japan)
P-564 Is transfer on blastocyst stage related to a higher risk of pregnancy complications?
E. Marbán Bermejo (Spain)
P-565 Prevalence of Ovarian Hyperstimulation Syndrome (OHSS) and hypercoagulability in patients triggered by GnRH agonist for excessive follicular response: a systematic follow-up
M. Peigné (France)
P-566 Perinatal outcome of children born after vitri cation of blastocysts (9480 cycles with 3143 babies in 16 years experiences)
T. Mukaida (Japan)
P-567 Behavioural, cognitive, and motor performance of children born after intracytoplasmic sperm injection with testicular sperm at the age of ve
A. Meijerink (The Netherlands)
P-568 Economic evaluation of single versus double embryo transfer in IVF/ICSI: a systematic review
L. Maria Luisa (Spain)
P-569 Therapeutic effect of acupuncture on the outcomes of in vitro fertilization: evaluated by an updated systematic review and meta-analysis
Y. Meng (China)
P-570 Do internal audits increase pregnancy rates?
A.D. Deenadayal (Germany)
P-571 Blastocyst biopsy in PGD/PGS cycles does not increase the neonatal risk when compared to intracytoplasmic sperm injection cycles
H. He (China)
P-572 Perception of pain during the follicular puncture and post-operative (48 hours) under paracervical block and conscious sedation, a prospective study
B. Prieto Molano (Spain)
P-573 Letrozole use for infertility and the risk of congenital malformations: a systematic review and meta-analysis
E. Dahdouh (Canada)
P-574 Low immunogenicity potential of follitropin delta, a recombinant FSH preparation produced from a human cell line: Results from phase 3 trials (ESTHER-1 and ESTHER-2)
B. Buur Rasmussen (Denmark)
168